T. Rowe Price Associates’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-32,636
Closed -$734K 2929
2022
Q4
$734K Sell
32,636
-1,290
-4% -$29.4K ﹤0.01% 1946
2022
Q3
$811K Buy
33,926
+971
+3% +$31.3K ﹤0.01% 1866
2022
Q2
$959K Sell
32,955
-2,181
-6% -$97.4K ﹤0.01% 1918
2022
Q1
$3.26M Sell
35,136
-24,186
-41% -$2.1M ﹤0.01% 1554
2021
Q4
$5.65M Buy
59,322
+3,874
+7% +$531K ﹤0.01% 1481
2021
Q3
$9.91M Sell
55,448
-285
-0.5% -$63.4K ﹤0.01% 1417
2021
Q2
$16.4M Sell
55,733
-16,734
-23% -$4.95M ﹤0.01% 1345
2021
Q1
$19.5M Sell
72,467
-13,636
-16% -$4.15M ﹤0.01% 1280
2020
Q4
$19.9M Buy
86,103
+10,734
+14% +$2.88M ﹤0.01% 1229
2020
Q3
$18.9M Sell
75,369
-3,521
-4% -$834K ﹤0.01% 1171
2020
Q2
$21.3M Buy
+78,890
New +$21.6M ﹤0.01% 1128

Other funds holding BNR